Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Adler S and Bollu R | Glomerular endothelial cell injury mediated by shiga-like toxin-1. | 1998 | Kidney Blood Press. Res. | pmid:9661132 |
| Bode-Böger SM et al. | Chronic dietary supplementation with L-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo. | 1998 | Cardiovasc. Res. | pmid:9659460 |
| Aoki T et al. | Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis. | 1998 | Thromb. Haemost. | pmid:9657446 |
| Schuligoi R et al. | Effects of the cyclooxygenase-2 inhibitor NS-398 on thromboxane and leukotriene synthesis in rat peritoneal cells. | 1998 | Inflamm. Res. | pmid:9657255 |
| Bordia A et al. | Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. | 1998 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9654398 |
| Harada Y et al. | Differing profiles of prostaglandin formation inhibition between selective prostaglandin H synthase-2 inhibitors and conventional NSAIDs in inflammatory and non-inflammatory sites of the rat. | 1998 | Prostaglandins Other Lipid Mediat. | pmid:9653772 |
| Nagao T et al. | Effect of lipo-prostaglandin E1 on crescentic-type anti-glomerular basement membrane nephritis in rats. | 1998 | Eur. J. Pharmacol. | pmid:9650829 |
| Assaley J et al. | Effects of magnesium sulfate infusion upon clotting parameters in patients with pre-eclampsia. | 1998 | J Perinat Med | pmid:9650132 |
| Mainwaring RD et al. | Complement activation and cytokine generation after modified Fontan procedure. | 1998 | Ann. Thorac. Surg. | pmid:9647087 |
| Whiteford M et al. | Effect of liposome-encapsulated hemoglobin on the development of endotoxin-induced shock in the rat. | 1998 | Shock | pmid:9645495 |
| RogovyÄ IuE | [Beta 2-microglobulin as a criterion of dysfunction in the regulation of proximal tubular activity in mercuric chloride-induced nephropathy]. | 1998 May-Jun | Urol Nefrol (Mosk) | pmid:9644989 |
| Li S and Tian H | [Oral low-dose magnesium gluconate preventing pregnancy induced hypertension]. | 1997 | Zhonghua Fu Chan Ke Za Zhi | pmid:9642379 |
| Bereczki C et al. | Increased platelet thromboxane release in focal segmental glomerulosclerosis. | 1998 | Nephrol. Dial. Transplant. | pmid:9641208 |
| Tu Y et al. | Effect of intra-arachnoid space perfusion on thromboxane A and prostacycline in experimental spinal cord injury. | 1997 | J. Tongji Med. Univ. | pmid:9639784 |
| Lees P et al. | Pharmacodynamics and pharmacokinetics of tolfenamic acid in ruminating calves: evaluation in models of acute inflammation. | 1998 | Vet. J. | pmid:9638074 |
| Cadroy Y et al. | Arachidonic acid enhances the tissue factor expression of mononuclear cells by the cyclo-oxygenase-1 pathway: beneficial effect of n-3 fatty acids. | 1998 | J. Immunol. | pmid:9637532 |
| Franconi F et al. | Further insights into the anti-aggregating activity of NMDA in human platelets. | 1998 | Br. J. Pharmacol. | pmid:9630340 |
| Ozyazgan I et al. | Eicosanoids and inflammatory cells in frostbitten tissue: prostacyclin, thromboxane, polymorphonuclear leukocytes, and mast cells. | 1998 | Plast. Reconstr. Surg. | pmid:9623831 |
| Gust R et al. | Synergistic hemodynamic effects of low-dose endotoxin and acute lung injury. | 1998 | Am. J. Respir. Crit. Care Med. | pmid:9620928 |
| Bassiouny HS et al. | Low flow enhances platelet activation after acute experimental arterial injury. | 1998 | J. Vasc. Surg. | pmid:9620144 |